Treatment of hepatocellular carcinoma during the COVID‐19 outbreak: The Working Group report of JAMTT‐HCC

This contingency guide was formulated on the premise that delivering standard treatment for hepatocellular carcinoma (HCC) has come under strain due to the coronavirus (COVID‐19) pandemic. Measures required are likely to vary largely across regions and individual institutions, depending on the level...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Masatoshi, Kurosaki, Masayuki, Ikeda, Masafumi, Aikata, Hiroshi, Hiraoka, Atsushi, Torimura, Takuji, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361293/
https://www.ncbi.nlm.nih.gov/pubmed/32583525
http://dx.doi.org/10.1111/hepr.13541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361293/
https://www.ncbi.nlm.nih.gov/pubmed/32583525
http://dx.doi.org/10.1111/hepr.13541

Ejemplares similares